Login
$BLLN
$114.07 +$2.60 (2.34%) Close

$BLLN SEC Filings

Filed On Filing
19 Oct 2026 Form 4: Lynch Thomas P., See Remarks

Received 2,000 shares by exercise or conversion ($17.3K)

16 Oct 2026 Form 4: Atay Oguzhan, Director

Received 3,183 shares by exercise or conversion ($8.91K) · Sold 5,850 shares ($574K) · Received 5,150 shares by exercise or conversion ($14.4K) · 1 more

15 Oct 2026 144
14 Oct 2026 Form 4: Atay Oguzhan, Director

Received 16,667 shares by exercise or conversion ($46.7K) · Sold 19,334 shares ($1.82M)

14 Oct 2026 144
14 Oct 2026 144
13 Oct 2026 Form 4: Lynch Thomas P., See Remarks

Received 8,000 shares by exercise or conversion ($69.2K)

13 Oct 2026 144
13 Oct 2026 144
07 Oct 2026 Form 4: Tsao David, Director

Received 20,000 shares by exercise or conversion ($56K) · Sold 20,000 shares ($2.16M)

07 Oct 2026 Form 4: ten Bosch John Roderick, SVP of Laboratory Operations

Sold 2,834 shares ($298K)

05 Oct 2026 144
05 Oct 2026 144
05 Oct 2026 144
30 Sep 2026 Form 4: Atay Oguzhan, Director

Received 8,333 shares by exercise or conversion ($23.3K) · Sold 10,999 shares ($1.33M)

28 Sep 2026 Form 4: Tsao David, Director

Received 3,333 shares by exercise or conversion ($9.33K) · Sold 3,333 shares ($417K)

28 Sep 2026 Form 4: ten Bosch John Roderick, SVP of Laboratory Operations

Sold 1,416 shares ($170K)

28 Sep 2026 144
28 Sep 2026 144
24 Sep 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support